Glenmark Pharmaceuticals Limited GLENMARK

Latest filings

• Routine15 28 Sept, 18:16 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
• General25 23 Sept, 08:41 · NSE
  A press release dated September 23, 2026, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S
• Routine15 21 Sept, 14:58 · BSE
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst/ Institutional Investor Meetings
• Routine15 21 Sept, 14:52 · NSE
  Schedule of meet
• Routine15 11 Sept, 18:54 · BSE
  Proceedings of the 48th AGM of the Company is enclosed
• Routine15 11 Sept, 18:54 · NSE
  Srutinizers report along with voting results.
• General25 11 Sept, 08:50 · NSE
  A press release dated September 11, 2026, titled "Glenmark Expands Global Respiratory Innovation Footprint with RYALTRIS® Launch in Brazil ".
• Credit rating73 11 Sept, 08:44 · NSE
  Credit Rating
• General25 21 Aug, 08:52 · BSE
  Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
• General25 21 Aug, 08:52 · NSE
  A press release dated August 21, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Calcium Gluconate Injection USP, 1,000 mg/10 mL (100 mg/mL), 5,000 mg/50 mL (100 mg/mL) Single-Dose Vials and 10,000 mg/100 mL (100 mg/mL) Pharmacy Bulk Package".

Shown 15 minutes after publication. Real time with Pro.